# Effects of Pioglitazone on Exogenous Carbohydrate Oxidation During Steady-State Exercise at High Altitude

> **NCT06164665** · PHASE4 · COMPLETED · sponsor: **United States Army Research Institute of Environmental Medicine** · enrollment: 9 (actual)

## Conditions studied

- High Altitude

## Interventions

- **DRUG:** Pioglitazone 15mg
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT06164665
- **Lead sponsor:** United States Army Research Institute of Environmental Medicine
- **Sponsor class:** FED
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-03-01
- **Primary completion:** 2023-07-01
- **Final completion:** 2023-07-01
- **Target enrollment:** 9 (ACTUAL)
- **Last updated:** 2026-03-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06164665

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06164665, "Effects of Pioglitazone on Exogenous Carbohydrate Oxidation During Steady-State Exercise at High Altitude". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT06164665. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*